Oramed pharmaceuticals inc. (ORMP)
CashFlow / Yearly
Aug'19Aug'18Aug'17Aug'16Aug'15Aug'14Aug'13Aug'12Aug'11
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS FOR THE PERIOD

-14,355

-12,727

-10,480

-10,964

-7,232

-5,696

4,232

-3,344

-1,561

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation

8

6

5

4

4

6

5

-

28

Depreciation

-

-

-

-

-

-

-

15

-

Amortization of debt discount

-

-

-

-

-

-

-

-

0

Exchange differences and interest on deposits and held to maturity bonds

183

-22

-124

163

20

29

-19

-62

30

Changes in fair value of investments

-437

-

-

-

-

-

-

-

-

Stock-based compensation

808

1,547

1,575

634

1,347

1,468

719

271

529

Shares issued for services

55

99

72

101

93

102

244

108

227

Gain on sale of investment

-

-

-

-

-

80

50

0

-

Exchange of warrants

-

-

-

-

-

-

297

-

-

Changes in fair value of warrant liabilities

-

-

-

-

-

-

-45

-

-

Gain on sale of investment

-

-

-

-

-

-

-

-

1,033

Impairment of investment

-

-

-

-

-

-

-

-

0

Imputed interest

-

-

-

-

-

-

-

-

3

Impairment of available for sale securities

-

-

-

-

-

-

-

184

197

Changes in fair value of warrant liabilities

-

-

-

-

-

-

-

-143

-

Changes in fair value of warrant liabilities

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

468

415

-39

71

-

-

-

31

36

Prepaid expenses and other current assets

-

-

-

-

-345

319

3

-

-

Accounts payable, accrued expenses and related parties

501

-612

1,257

470

16

475

-146

-

-

Deferred revenues

297

-2,449

1,520

14,266

500

0

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-0

Accounts payable and accrued expenses

-

-

-

-

-

-

-

203

-17

Liability for employee rights upon retirement

2

2

4

3

2

1

1

-2

22

Provision for uncertain tax position

-

-

-

15

1

-4

205

-

-

Other liabilities

-42

-130

53

390

0

0

-

-

-

Provision for uncertain tax position

-

-

-

-

-

-

-

90

-36

Total net cash used in operating activities

-12,940

-14,657

-5,831

4,655

-4,946

-4,068

-3,396

-2,301

-1,705

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term deposits

24,990

7,101

3,557

7,010

3,673

49,250

-

475

1,700

Purchase of long-term deposits

4,237

15,040

17,230

22,274

17,452

6,500

-

-

-

Purchase of held to maturity securities

1,357

4,429

3,869

1,775

1,885

0

0

-

-

Purchase of short-term and long-term deposits

-

-

-

-

-

-

5,847

-

-

Proceeds from sale of short term deposits

-

-

-

-

-

-

-

-

0

Proceeds from sale of short-term deposits

38,611

17,316

26,551

14,160

19,701

42,539

1,054

1,800

0

Proceeds from maturity of held to maturity securities

3,250

2,257

2,417

900

0

0

-

-

-

Proceeds from sale of available-for-sale securities

-

-

-

-

-

137

227

-

-

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

450

-

Funds in respect of employee rights upon retirement

3

2

3

2

2

2

2

4

-

Purchase of property and equipment

15

5

7

9

1

14

6

2

2

Funds in respect of employee rights upon retirement

-

-

-

-

-

-2

-5

0

3

Lease deposits, net

-

-

-

-

-

-

-

-

-2

Total net cash provided by investing activities

11,259

-7,004

4,302

-16,010

-3,312

-13,088

-4,569

1,769

-1,703

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants, net of issuance costs

-

21,657

25

-

-

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

10,594

9,713

14,887

5,715

-

-

Proceeds from exercise of warrants and options

-

997

1,561

1,449

8

1,753

109

0

-

Proceeds from shares to be issued for exercise of warrants

-

-

-

-

-

-

-

3,489

3,694

Receipts on account of shares issuances

-

-

-

-

-

-

-

-

0

Proceeds from convertible notes

-

-

-

-

-

-

-

-

0

Proceeds from short term note payable

-

-

-

-

-

-

-

-

0

Payments of short term note payable

-

-

-

-

-

-

-

-

0

Shareholder advances

-

-

-

-

-

-

-

-

0

Total net cash provided by financing activities

-

22,654

1,586

12,043

9,721

16,640

5,824

3,489

3,694

EFFECT OF EXCHANGE RATE CHANGES ON CASH

14

34

5

6

-12

6

-18

-39

28

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-1,667

1,027

62

694

1,451

-510

-2,159

2,918

313

SUPPLEMENTARY DISCLOSURE ON CASH FLOWS -
Interest received

929

826

833

256

115

107

-

-

-

Taxes paid

300

-

400

-

-

-

-

-

-

Exchange of warrants

-

-

-

-

-

-

918

-

-

Shares issued for marketable securities

-

-

-

-

-

-

628

-

-

Shares issued for offering costs

-

-

-

-

-

-

-

-

76

Exchange of warrants

-

-

-

-

-

-

-

0

-

Shares issued for marketable securities

-

-

-

-

-

-

-

0

-

Shares and warrants to be issued for cash

-

-

-

-

-

-

-

25

-